Scott D Newsome 1 2, Fan Tian 3, Thomas Shoemaker 4, Kathryn C Fitzgerald 5 6, Sandra D Cassard 5 6, Julie Fiol 7, Sarah Snoops 5 6, David S Cooper 8, Jennifer S R Mammen 8, Pavan Bhargava 5 6, Ellen M Mowry 5 6, Peter A…

  Press Release Multiple Sclerosis Coalition Applauds World Health Organization Decision Decision to add MS treatments to Essential Medicines List…

 Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Positive Results Announced from Phase 3 OCARINA II…

 Click to Subscribe for the MS Beacon eNewsletter, resources and MS education Stem cell therapy highly effective in active RRMS:…

Pathways to Cures Global Summit  I (Stuart Schlossman) was fortunate to have been asked, and to have attended this Global…

 Phase 2b extension trial now has 125 MS patients on 60 mg daily dose About 2.5 years of treatment with tolebrutinib was…

 Created on Sunday, 26 March 2023 14:33 by Alan M Dattner, MD     [email protected]   I was excited to see the studies…

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study…

 Antibodies in spinal fluid seen to drive PPMS, but not relapsing MS by Marisa Wexler, MS | February 7, 2023…

 Biomarkers show weak correlation with PPMS activity and severity  by Patricia Valerio, PhD | November 25, 2022 Individuals with primary progressive multiple sclerosis (PPMS) have…